🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to describe the nicotine pharmacokinetic (PK)...
Status
Completed
Location
Celerion
Start Date
2023-02-16
Trial ID
NCT05789420
This is a human randomized controlled cross-over study where we investigate...
Status
Completed
Location
Institutionen för kliniska vetenskaper, Danderyds sjukhus
Start Date
2021-10-01
Trial ID
NCT05260827
Treatments Being Tested
This is a single-center, open-label, parallel-cohort study to measure and c...
Status
Completed
Location
Clinical Research Atlanta
Start Date
2022-05-23
Trial ID
NCT05363254
This is a randomised, cross-over, open-label, confinement study conducted i...
Status
Completed
Location
Celerion
Start Date
2023-07-07
Trial ID
NCT06093659
Treatments Being Tested
This is a multi-site, open-label, 8-week, prospective observational study, ...
Status
Completed
Location
Schlesinger Atlanta
Start Date
2021-10-26
Trial ID
NCT05102786
Although the well-known detrimental effects of conventional cigarette smoki...
Status
Completed
Location
Addendo srl
Start Date
2021-10-18
Trial ID
NCT04649645
Treatments Being Tested
This project examines the influence of flavor availability on switching to ...
Status
Completed
Location
Virginia Commonwealth University
Start Date
2022-11-28
Trial ID
NCT05499377
Treatments Being Tested
The purpose of the study is to evaluate changes in biomarkers of exposure (...
Status
Completed
Location
Pillar Clinical Research
Start Date
2023-10-02
Trial ID
NCT06179290
Moderate to severe sleep apnea (a high number of breathing pauses on a slee...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2011-03
Trial ID
NCT01261390
This was a randomized, controlled, open-label, 4 parallel arm study with a ...
Status
Completed
Location
Celerion
Start Date
2022-11-04
Trial ID
NCT05599451
Treatments Being Tested